Loyens & Loeff assisted Mr. Kenneth Mulvany on the successful implementation of a shareholder proposal in BenevolentAI. Kenneth Mulvany, the founder and principal shareholder of BenevolentAI,...
BenevolentAI’s Shareholder Proposal
Loyens & Loeff Appoints Four New Partners
Leading Law & Tax Firm Loyens & Loeff has appointed four new partners effective 1 January 2024. Menno Baks, Noémi Gémesi, Tjebbe Gerverdinck and Pleuni Visser...
Lucas Bols’ €269.5m Public Offer Agreement with Nolet
Loyens & Loeff assisted Lucas Bols N.V. on their agreement. Nolet Group, owner of Ketel One Vodka, and the historic Amsterdam-based distillery Lucas Bols have finalized...
Wallbox N.V.’s $100 Million ATM Offering Programme
Loyens & Loeff acted for Wallbox on the matter. On April 5th, Wallbox (NYSE:WBX) submitted a prospectus supplement to the Securities and Exchange Commission (SEC) regarding its current...
European Healthcare Acquisition & Growth Company B.V. ‘s Business Combination with Croma-Pharma GmbH
Flick Gocke Schaumburg, Houthoff and Sullivan & Cromwell acted for European Healthcare Acquisition & Growth Company B.V., while Loyens & Loeff and DORDA assisted Croma-Pharma. European...
Redefine’s Acquisition of ALL of the Shares in EPP N.V.
Loyens & Loeff advised EPP N.V. on the deal. Redefine Properties Limited (Redefine) launched a share-for-share takeover offer to acquire all of the shares in EPP N.V....